Trend > The Science > Why the FDA rejected fluvoxamine as a Covid-19 drug
Why the FDA rejected fluvoxamine as a Covid-19 drug
The FDA made a reasonable decision — but one that still shows much of what’s wrong with our current system for emergency approvals.

Why the FDA rejected fluvoxamine as a Covid-19 drug

The FDA made a reasonable decision — but one that still shows much of what’s wrong with our current system for emergency approvals.